Top

Published in:

01-03-2005 | Editorial

Ablative Therapy for Liver Cancer: Which?

Author: David L. Morris, MD

Published in: Annals of Surgical Oncology | Issue 3/2005

Excerpt

I am most grateful for the opportunity to reply to the editorial “The End of Cryotherapy for the Treatment of Nonresectable Hepatic Tumors?” (in this issue). This is real progress now that we are not arguing about ablation or not for liver tumor ablation, but rather about the type of ablation. Radiofrequency ablation (RFA) is undoubtedly an important treatment option, and it is much easier to use percutaneously, although it is yet to be established whether percutaneous RFA can achieve results as good as RFA or cryotherapy at laparotomy. Studies to date have tended to indicate that open RFA is associated with considerably better outcomes and that intraoperative findings alter the planned treatment in more than a half of cases.1 …

Wallace, JR, Christians, KK, Quiroz, FA, Foley, WD, Pitt, HA, Quebbeman, EJ 2001Ablation of liver metastasis. Is pre operated imaging sufficiently accurate?J Gastrointest Surg598107PubMed

Yan, DB, Clingan, P, Morris, DL, et al. 2003Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many?Cancer9832030PubMed

Dwerryhouse, SJ, Seifert, JK, McCall, JL, Iqbal, J, Ross, WB, Morris, DL 1998Hepatic resection with cryotherapy to involved or inadequate resection margin (edge freeze) for metastases from colorectal cancerBr J Surg851857PubMed

Seifert, JK, France, MP, Zhao, J, et al. 2002Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumour necrosis factor alpha in a rat modelWorld J Surg26133341PubMed

Stewart, GJ, Preketes, A, Horton, M, Ross, WB, Morris, DL 1995Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in manCryobiology322159PubMed

Pearson, AS, Izzo, F, Fleming, RY 1999Intra operative radiofrequency ablation or cryo ablation for hepatic malignanciesAm J Surg17859228

Livraghi, T, Goldberg, SN, Monti, F, et al. 1997Saline enhanced radio frequency tissue ablation in the treatment of liver metastasesRadiology20220210

Solbiati, L, Ierace, T, Goldberg, SN, et al. 1997Percutaneous US guided radiofrequency tissue ablation of liver metastases: treatment and follow up in 16 patientsRadiology202197203

Nagata, Y, Hiraoka, M, Nishimura, Y, et al. 1997Clinical results of radio frequency hyperthermia for malignant liver tumorsInt J Radiat Oncol Biol Phys3835965PubMed

Mazziotti, A, Grazi, GL, Gardini, A, et al. 1998An appraisal of percutaneous treatment of liver metastasesLiver Transpl Surg42715PubMed

Adam, R, Hagopian, EJ, Linhares, M, et al. 2002A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignanciesArch Surg13713329CrossRefPubMed

Seifert, K, Morris, DL 1999Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancerBr J Surg8623440PubMed

Lencioni, RA, Allgaier, HP, Cioni, D, et al. 1999Percutaneous treatment of small hepatocellular carcinoma in cirrhosis: radio frequency thermal ablation vs ethanol injectionRadiology213123

Omata, M, Tateishi, R, Yoshida, H, Shiina, S, et al. 2000Prospective randomized controlled trial comparing percutaneous radiofrequency ablation and percutaneous ethanol injection therapy for small hepatocellular carcinomaGastroenterology118959CrossRef

Olschewski M, Lencioni H, Allgaier HP, et al. A randomized comparison of radio frequency thermal ablation and percutaneous ethanol injection for the treatment of small hepatocellular carcinoma (abstract). Proc Am Soc Clin Oncol 2001;500

Nakada, SY, Jerde, TJ, Warner, TF, Lee, FT,Jr, et al. 2004Comparison of radiofrequency ablation cryoablation and nephrectomy in treating implanted VX2 carcinoma in rabbit kidneysJ Endourol185016PubMed

Collyer, WC, Landman, J, Olweny, EO, et al. 2001Comparison of renal ablation with cryotherapy, dry radiofrequency and saline augmented radiofrequency in a porcine modelJ Am Coll Surg19350513CrossRefPubMed

Title: Ablative Therapy for Liver Cancer: Which?
Author: David L. Morris, MD
Publication date: 01-03-2005
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 3/2005
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/ASO.2005.12.915

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ablative Therapy for Liver Cancer: Which?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2005

Significance of Histological Response to Preoperative Chemoradiotherapy for Pancreatic Cancer

Incidence and Clinical Significance of Lymph Node Metastasis Detected by Cytokeratin Immunohistochemical Staining in Ductal Carcinoma In Situ

Radiation-Induced Sarcoma: A Challenge for the Surgeon

Desmoplastic Melanoma: A Heterogeneous Entity in Which Subclassification as “Pure” or “Mixed” May Have Important Prognostic Significance

Prognostic Factors for Survival in Patients With Locally Recurrent Extremity Soft Tissue Sarcomas

The End of Cryotherapy for the Treatment of Nonresectable Hepatic Tumors?